The Reimbursement and Payer Committee:
The Board has determined that all of the prospective members of the Reimbursement an Payor Committee are “independent,” as defined by NASDAQ listing standards. The responsibility of the Reimbursement and Payor Committee is to review, set, draft and approve the reimbursement protocols with the government agencies and payors. The Reimbursement & Payor Committee has also been appointed by the board.
The Development Plan Oversight Committee:
The Board has determined that all of the prospective members of the Development Plan Oversight Committee are “independent,” as defined by NASDAQ listing standards. The responsibility of the Development Plan Oversight Committee is to review, set, draft and approve the Development Plan between CVR Medical and CVR Global and to provide all oversight pertaining to milestones achieved against GAANT, payment and subsequent audit of all invoices received for services performed by CVR Global and to make any recommendations to the Board of Directors regarding any changes to the Development Plan needed.
The Audit Committee:
The Audit Committee will consist of Dr. Phil Blunden, and Dallas Hack. The board has determined that all of the prospective members of the Audit Committee are “independent,” as defined by the NASDAQ listing standards and by applicable SEC rules. . The function of the Audit Committee relates to oversight of the auditors, the auditing, accounting, and financial reporting processes, and the review of the Company’s financial reports and information. In addition, the functions of the Audit Committee will include, among other things, recommending to the board the engagement or discharge of independent auditors, discussing with the auditors their review of the Company’s quarterly results and the results of their audit, and reviewing the Company’s internal accounting controls.
Dr. Phil Blunden
Dallas Hack (Chair)
The Compensation Committee:
The Board has determined that all of the prospective members of the Compensation Committee are “independent,” as defined by NASDAQ listing standards. The responsibility of the Compensation Committee is to review and approve the compensation and other terms of employment of our Chief Executive Officer and our other executive officers, including all of the executive officers named in the Summary Compensation Table under the heading “Executive Compensation” below (the “Named Executive Officers”). Among its other duties, the Compensation Committee oversees all significant aspects of the Company’s compensation plans and benefit programs. The Compensation Committee annually reviews and approves corporate goals and objectives for the Chief Executive Officer’s compensation and evaluates the Chief Executive Officer’s performance in light of those goals and objectives. The Compensation Committee also recommends to the Board the compensation and benefits for members of the board. The Compensation Committee has also been appointed by the board to administer our Stock Option Plan. The Compensation Committee does not delegate any of its authority to other persons.
The Nominating & Corporate Governance Committee:
The committee members are independent under applicable NASDAQ rules and regulations. The Nominating and Corporate Governance Committee is responsible for, among other things, considering potential board members, making recommendations to the full board as to nominees for election to the board, assessing the effectiveness of the board and implementing our corporate governance guidelines.
Code of Business Conduct and Ethics and Insider Trading Policy
Our board of directors will adopt a Code of Ethical Conduct and an Insider Trading Policy.